Wittek Research Foundation for Hypertrophic Cardiomyopathy

Dedicated to supporting research that will transform the prevention, diagnosis, and treatment of hypertrophic cardiomyopathy.

The second annual meeting of the Wittek Research Foundation for Hypertrophic Cardiomyopathy was held on November 11, 2023 in Philadelphia. Under the guidance of the members of our scientific advisory board, the goals of this half-day meeting was to identify the current state patient reporting outcome tools and strategies for future developments in this area. Participants represented cardiologists, patient advocates, representatives from the pharmaceutical industry and the federal drug administration.

Wittek Research Foundation for Hypertrophic Cardiomyopathy is a 501(c)(3) nonprofit (EIN 86-1682122) based in Tenafly, NJ.